The tariff classification of oro-nasal masks from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the AF531 oro-nasal full-face masks will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The rate of duty will be free.
Ruling text
In your letter dated February 24, 2025, you requested a tariff classification ruling on behalf of your client Philips RS North America LLC. Additional information was provided by email, dated March 13, 2025. The products under consideration are twenty Respironics AF531 oro-nasal full-face masks. In the future, please limit your request to no more than five items.
The masks can be divided into two categories: AF531 EE oro-nasal masks (further broken down by EE Leak 1 and EE Leak 2 masks) and AF531 SE oro-nasal masks. Each is composed of a mask frame, an elbow, a mask cushion, and a headgear. They are designed to be used on patients 7 years or older weighing more than 20kg.
AF531 EE oro-nasal masks are single use and available in different elbow (EE Leak 1 and EE Leak 2) and headgear (CapStrap headgear or four-point headgear) configurations and in different sizes targeted for the United States or the global market. Part numbers 1061733 through 1061735, 1072618 through 1072620, 1072622, 1072623, 107628, and 1072633 are AF531 EE Leak 1 oro-nasal masks. Part numbers 1100390 through 1100395 are AF531 EE Leak 2 oro-nasal masks.
You indicate that the AF531 EE Leak 1 and EE Leak 2 oro-nasal masks are used with CPAP (continuous positive airway pressure) devices or BiPAP (bilevel positive airway pressure) devices and are intended to provide an interface for application of CPAP or bilevel therapy to patients with chronic sleep apnea in the hospital/institutional environment.
Part numbers 1072624 through 1072626, and 1072631 through 1072632 are AF531 SE oro-nasal masks available in different headgears (CapStrap headgear or four-point headgear) and sizes. You indicate that these masks are used with PAP (positive airway pressure) ventilators to provide a patient interface for application of noninvasive ventilation and are intended to administer CPAP or positive pressure ventilation to treat chronically ill patients in the hospital/institutional environment only.
The applicable subheading for the AF531 oro-nasal full-face masks will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The rate of duty will be free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e. 9903.01.24, in addition to subheading 9019.20.0000, HTSUS, listed above.
However, the additional duties imposed by heading 9903.01.24 shall not apply to goods for which entry is properly claimed under a provision of chapter 98 of the tariff schedule pursuant to applicable regulations of U.S.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N346236).